Related Experiment Video
Updated: Mar 3, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Sustainable Strategies in Tuberculosis Management: Bridging Ethnobotanical Pharmacology, Advanced Drug Delivery, and
Reem Abou Assi1,2,3, Antonia Morita Iswari Saktiawati2,4,5, Isil Aksan Kurnaz2,6,7
1Department of Pharmacy, Al-Qabas College, Mosul, Iraq.
Abstract:
Tuberculosis (TB) persists as a leading infectious disease, with progress in global control complicated by emerging drug resistance, limited access to new therapies, and persistent health disparities. This review presents a comprehensive synthesis of traditional and innovative strategies to combat TB, spanning ethnobotanical and folk medicine practices from Africa, Asia, India, Latin America, and Indigenous communities, integrated within World Health Organization frameworks for traditional medicine. The work is systematically bridging time-honored folk therapies with state-of-the-art advances in drug discovery and machine learning algorithms, nanotechnology-based delivery, and artificial intelligence, evaluating both synergy and unique roles in TB management. Additionally, TB stewardship is critically analyzed through nanocarrier platforms (liposomes, mesoporous silica, graphene oxide), artificial intelligence-driven virtual screening, and host-directed therapies, emphasizing their potential for personalization, improved bioavailability, and overcoming drug resistance. This review underscores the urgent need for the sustainable and ethical production of natural anti-TB agents, considering climate change-induced resource loss. Thus, it is providing a roadmap for integrating traditional knowledge with biomedical research, supporting equitable, culturally sensitive, and ecologically responsible TB care.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Microorganisms in Medicine and Therapeutics
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

